Filing Flows › Idexx Laboratories (IDXX) › Q1 2026
Idexx Laboratories (IDXX) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 5, 2026
Idexx Laboratories (IDXX) reported revenue of $1.1B for the first quarter 2026 (Q1 2026), +14% from a year earlier and +5% from the quarter before. Operating margin was 31.8%, net earnings $278M (24.4% of revenue).
Idexx Laboratories, Q1 2026: revenue $1.1B (+14% year over year), operating margin 31.8%, net earnings $278M, operating cash flow $266M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1B | +5% | +14% |
| Gross profit | $723M | +10% | +16% |
| Operating profit | $363M | +15% | +15% |
| Net earnings | $278M | +12% | +15% |
| Operating cash flow | $266M | -25% | +12% |
| Free cash flow | $234M | -28% | +13% |
What changed
Revenue was $1.1B in Q1 2026, up 14% year over year and up 5% from the previous quarter. Product revenue was the largest line at 58% of revenue. Product revenue added $0.09B year over year (up 16%), 65% of the total change.
Gross margin was 63.4%, up 0.9 points from Q1 2025. Operating profit was $0.36B, a 31.8% margin (up 0.1 points year over year). Of the extra revenue versus Q1 2025, 32% reached operating profit, above the 32% margin then. Operating expenses grew 17% against revenue growth of 14%. The fastest-growing cost line was General & admin (+30%). Net earnings were $0.28B, up 15% year over year. The effective tax rate was 21.7%.
Operating cash flow was $0.27B (up 12% year over year), 96% of net earnings. Non-cash charges added back $0.04B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.07B. Capital expenditures of $0.03B left free cash flow of $0.23B.
Questions
What was Idexx Laboratories' revenue in the first quarter 2026?
Idexx Laboratories (IDXX) reported revenue of $1.1B for the first quarter 2026 (Q1 2026), +14% from a year earlier and +5% from the quarter before.
Was Idexx Laboratories profitable in the first quarter 2026?
Operating profit was $363M (31.8% of revenue) and net earnings $278M.
Source: Idexx Laboratories 10-Q on SEC EDGAR.